Global Clinical Trial Supplies Market Size & Trends
The growing number of clinical trials across the globe, stringent regulatory restrictions, and guidelines for drug approval that varies region by region, growing incidence of infections, and rising investment in cancer research are expected to propel the clinical trial supplies market forward.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC on "Global Clinical Trial Supplies Market - Forecast to 2027'' https://www.globalmarketestimates.com/market-report/clinical-trial-supplies-market-3890
By Clinical Phase (Phase I, Phase II, Phase III, Others), By Service (Manufacturing, Storage & Distribution, Supply Chain Management), By Therapeutic Use (Oncology, Diabetes), By End Use (Pharmaceuticals, CROs), By Region (North America, Asia Pacific, Central, and South America, Europe, and the Middle East and Africa), Competitive Landscape Company Market Share Analysis, and Competitor Analysis
Key Market Insights
• As per the clinical phase outlook, the Phase 3 segment is expected to be the largest segment in the clinical trial supplies market from 2022 to 2027
• The Asia Pacific region is analyzed to be the fastest-growing segment in the market
• United States has the largest share in the market during the forecast period of 2022-2027.
• As per the service, the supply chain management segment is expected to be the largest segment in the clinical trial supplies market from 2022 to 2027
• Catalent, Inc. (US), Almac Group (UK), Biocair (US), SIRO Clinpharm Private Limited (India), Sharp (Japan), Parexel International Corporation (US), Alium Medical Limited (UK), Ancillare, LP. (US) and Thermo Fisher Scientific Inc. (US) among others, are some of the key players in the clinical trial supplies market.
Clinical Phase Outlook (Revenue, USD Billion, 2022-2027)
• Phase I
• Phase II
• Phase III
Service (Revenue, USD Billion, 2022-2027)
• Storage & Distribution
• Supply Chain Management
Therapeutic Use Outlook (Revenue, USD Billion, 2022-2027)
End Use Outlook (Revenue, USD Billion, 2022-2027)
Regional Outlook (Revenue, USD Billion, 2022-2027)
• The U.S.
• Rest of Europe
• South Korea
• Rest of APAC
Central & South America
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of MEA
Contact: Yash Jain
Email address: email@example.com
Phone Number: +1 6026667238
B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India
Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Clinical Trial Supplies Market Size & Trends here
News-ID: 2698212 • Views: 245
More Releases from Global Market Estimates Research & Consultants
Allogeneic Cell Therapy Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Allogeneic Cell Therapy Market is projected to grow from USD 994.9 million in 2022 to USD 1,570.1 million by 2027 at a CAGR of 9.6% from 2022 to 2027. Browse 155 Market Data Tables and 133 Figures spread through 156 Pages and in-depth TOC on "Global Allogeneic Cell Therapy Market - Forecast to 2027'' https://www.globalmarketestimates.com/market-report/allogeneic-cell-therapy-market-3894
MHC Multimers Market Size & Analysis
According to a new market research report published by Global Market Estimates, the Global MHC Multimers Market is projected to grow at a CAGR value of 4.8% from 2022 to 2027. Immudex, Sigma-Aldrich, JPT Peptide Technologies, Creative Biolabs, ProImmune, MBL International, BioLegend, Altor BioScience Corporation, Immunaware, Bio X Cell, and Sanquin, among others, are the some of the key players in the MHC multimers market. Browse 155 Market Data Tables and
Oncology Sequencing Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Oncology Sequencing Market is projected to grow at a CAGR of 13.5% from 2022 to 2027. Thermo Fisher Scientific, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., QIAGEN, BGI, Agilent Technologies, Guardant Health, Biocept, Inc., Myriad Genetics, Inc., and eviCore healthcare among others, are some key players in the oncology sequencing market. Browse 151 Market Data Tables and
Global AI in Education Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global AI in Education Market is projected to grow from USD 3.79 Billion in 2022 to USD 20.54 Billion in 2027 at a CAGR value of 45.6% from 2022 to 2027. The increasing use of mobile devices to access educational programs and study materials, such as smartphones, tablets, and laptops, has prompted software developers to create software that
More Releases for Phase
PanAfGeo: The Second Phase Begins!
The PanAfGeo community is pleased to announce the launching of the PanAfGeo second phase (PanAfGeo-2), which will continue to build on the first phase project’s achievements over the next three years. PanAfGeo, an EU co-funded initiative that began in 2016, contributed to the transfer of knowledge between European and African Geological Surveys. PanAfGeo also ensured the institutional strengthening of many African national administrations in charge of geology and mining. With the backing
COVID-19 - Pipeline Analysis 2020 for Global Market | Emphasis on Products cover …
COVID-19 (also known as Anderson COVID-19)?is a viral disease caused by RNA virus, SARS-CoV-2 or commonly known as corona virus. These viruses can cause respiratory, enteric, hepatic, and neurologic diseases. At the end of 2019, a new coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, China. It rapidly spread, resulting in an epidemic throughout China, followed by an increasing number of cases in other
Power Metering Market Information by type (smart, digital, analog), by phase (si …
Power Metering Market Information by type (smart, digital, analog), by phase (single phase, three phase) by application (residential, commercial and industrial) and Region - Forecast to 2022 The report for Global Power Metering Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and
HIV Vaccines Market Perceive Aggrandized Growth at a CAGR of 11.48% Till 2023 | …
HIV Vaccines Market Report Added on MarketResearchFuture.com with Overall Analysis. Key developments and Strategies Cover in this Report. The Market for Expected to Grow Globally Over the CAGR of 5 % During the Period 2018 to 2027 from USD 2,702.3 Billion in 2027. HIV Vaccines Market - Segmentation The global HIV vaccines market has been segmented on the basis of basis of antibiotics, type, and lastly, region. Antibiotics have been segmented into dicloxacillin,
2026 Global Pharmacovigilance Market Growth Analysis by Clinical Trials Like Pre …
Global Pharmacovigilance Market 2018 report includes extensive Market analysis and industry landscape along with SWOT analysis and PESTEL analysis of the important vendors. The analysis is conducted with a blend of secondary and primary advice for inputs from participants in the industry. Pharmacovigilance industry report covers the prospects of Women’S Health P oducts in the forecast period of 2018-2026 and the scenario. Growing prevalence of adverse reactions caused by drugs, has
MAAT Inaugurates Versatile Phase Shifter
Company announces release of a digital recreation of Roger Schult’s analog hardware MAAT Incorporated, a manufacturer of exceptional performance professional audio solutions, today announced the release of RSPhaseShifter version 1.0, a digital implementation of the Roger Schult/German Audio Lab’s Phase Shifter 500 Series W2324 hardware. The cross–platform plug–in creates a high quality, phase shifted version of a monaural or stereo input. Available in formats for all major DAWs (Digital Audio Workstations), RSPhaseShifter